Navigation Links
Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
Date:7/8/2008

Recent Inlog Acquisition Provides Established Cellular Therapy Solution

DENVER, July 8 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or "the Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced the immediate release in the United States of EdgeCell(TM), a proven cellular therapy software solution for tissue banks, stem cell laboratories and cord blood banks. EdgeCell, with an installed base in Europe, will provide U.S. customers with an established Cellular Therapy product that has been meeting the needs of a variety of European customers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

EdgeCell is a state-of-the-art Cellular Therapy software solution for hospitals, surgery centers and health care facilities. EdgeCell fully tracks the procurement process including the medical history questionnaire; any required testing including specimen reception and infectious disease testing; product preparation including packaging, labeling and storage as well as crossmatching and distribution. Along with an extensive list of safety features, EdgeCell incorporates full traceability and generation of regulatory documentation.

The complex nature of tissue banks, stem cell laboratories and cord blood banks dictates that distinct business rules and parameters be tailored to each type of product. EdgeCell meets this need through its ability to configure and maintain distinct business rules and parameters for each type of product be it tissue (bone parts, whole bone, cells, valves, cornea, skin, and other tissues), stem cells or cord blood. Inlog has the ISO 9001:2000 and NSF/ISO 25051/12119 certification for EdgeCell and its other products assuring the highest level of quality regarding the design, testing and validation of the software, the documentatio
'/>"/>

SOURCE Global Med Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Ready to hit the road? ... all drivers to get their vehicles ready. With handicapped vehicles, ... Advanced Driving Systems (ADS) is ready to help drivers get ... for summer road trips. , When planning for the big ... ensure that the trip goes smoothly and they are prepared ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 John A. ... to Cincinnati , The Department of Veterans Affairs (VA) ... Gennaro as the new director of the Cincinnati VA ... care to more than 43,000 unique Veterans annually and ... over 2,000 staff, CVAMC is a two-division campus located ...
(Date:5/29/2015)... May 29, 2015 According to a recent ... 10 full-time workers has a substance abuse problem - the ... than 111,500 adults with full-time jobs, revealed that 9.5% of ... previous year. (1) The National Council on Alcoholism and Drug ... year, and an estimated 70% of the 14.8 million illicit ...
(Date:5/29/2015)... Johnson & Johnson and its ... lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a California ... use of the antipsychotic medication. According to court ... third bellwether trial to involve male breast growth ... Pennsylvania’s Philadelphia Court of Common Pleas, where more ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Inspire Nexus, ... created a solution to the question many life coaches ... gain the experience and hours necessary to become a ... pondered this question, but not for long. Inspire Nexus, ... to hire Coaches directly. Coaches who have experience coaching ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... Jan. 12 Just because you are traveling or,on holiday ... good health habits.,In fact, it is an easier time to ... ) , Many Americans take to ... -- be it business or pleasure, and they often fall ...
... developers summit for companies interested in integrating NurseTesting ... ... (Vocus) January 12, 2009 -- Analysts and industry-watchers believe ... but also the entire nature of the business models that ...
... Medical Equipment the 17th fastest growing business in Louisville, Business First ... , ... (Vocus) January 12, 2009 -- DRE, Inc., a premier international ... of Louisville as a 2008 Company of the Year. The award caps ...
... open enrollment helps Medicare recipients make sure they,ve made the ... ... (Vocus) January 12, 2009 -- Although annual Medicare enrollment has ... during the current Medicare open enrollment period. That information comes ...
... Sweden The Swedish investment,company Karolinska Development AB has ... stem cell and other tissue engineering based,treatments for veterinary ... 2007 EvoStem Finland Oy introduced its first product TendoStem(R),which ... and ligament injuries,in horses. TendoStem(R) is currently on the ...
... Inc., a drug development company focusing on serious Central ... that it held an initial closing of $2.9 million ... will use the funds for the clinical development of ... slowing down disease progression and improving memory and cognition ...
Cached Medicine News:Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 3Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 4Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 2Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 3Health News:Business First Selects DRE Medical Equipment as a Company of the Year 2Health News:Business First Selects DRE Medical Equipment as a Company of the Year 3Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 2Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 3Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 4Health News:Medicare Advantage Open Enrollment Offers One-Time Chance to Change Your Mind: Allsup Outlines Rules for Switching Plans 5Health News:Karolinska Development Invests in EvoStem Finland Oy 2Health News:New Venture Funding for Alzheimer's Disease Drug Developer 2
(Date:5/29/2015)... 29, 2015  Eli Lilly and Company (NYSE: ... announced that they have entered into a clinical trial ... AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination ... antiangiogenic cancer medicine. The planned study will assess the ... tumors. The Phase I study is expected ...
(Date:5/29/2015)... prostate surgeon and New York Urologist, Dr. David Samadi ... Fusion-Guided Biopsy for detecting aggressive prostate cancer . ... Lenox Hill Hospital is the only center using the revolutionary ... City . We,ve seen tremendous improvement in detecting and ... an MRI makes for a much more accurate diagnosis, especially ...
(Date:5/28/2015)...  Eli Lilly and Company (NYSE: LLY ) announced ... offer for up to $1.6 billion aggregate principal amount of ... notes who tendered, and did not validly withdraw, their notes ... time, on May 27, 2015 (the early tender ... eligible to receive the total consideration. The total consideration for ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5
Test for determination of rheumatoid factor....
... The SYNCHRON CX4 Delta Specialty / ... access analyzer that can consolidate Drugs ... testing, such as thyroid, HbA1c and ... CX4 Delta offers a level of ...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
Medicine Products: